Biotimize is Brazil’s first Contract Development and Manufacturing Organization (CDMO) fully dedicated to biopharmaceuticals. Headquartered in Piracicaba, São Paulo, the company provides end-to-end solutions for the development and production of biologics — from cell line development and process optimization to non-clinical material supply. With a highly skilled multidisciplinary team and state-of-the-art technologies, Biotimize enables faster, more cost-efficient, and locally accessible innovation. Its mission is to maximize the development and production of biopharmaceuticals, making innovation accessible and economically viable so that transformative treatments reach those in need. As Biotimize advances towards building its GMP facility, it aims to become a key regional hub, bridging global innovation with the growing healthcare demands of Latin America.